Who is sponsoring NCT04456712?

NCT04456712 is sponsored by Beni-Suef University.

What drugs are being tested in NCT04456712?

Interventions in NCT04456712: Ciprofloxacin 400 MG/200 ML Intravenous Solution, Levofloxacin 750 MG.

What condition does NCT04456712 study?

NCT04456712 studies QTc Prolongation, Hyperglycemia, Hypoglycemia.

Is NCT04456712 still recruiting?

NCT04456712 is currently completed. Last updated 2 July 2020.

Last reviewed 2020-07-02 · How we verify

NCT04456712

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

Completed Phase 4 Last updated 2 July 2020

What this trial tests

Phase 4 trial testing Ciprofloxacin 400 MG/200 ML Intravenous Solution in QTc Prolongation, Hyperglycemia, Hypoglycemia in 200 participants. Completed in 30 December 2018.

Timeline

1 June 2018

Primary endpoint
30 November 2018

30 December 2018

Quick facts

Lead sponsor	Beni-Suef University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	200
Start date	1 June 2018
Primary completion	30 November 2018
Estimated completion	30 December 2018
Sites	1 location across Egypt

Drugs / interventions tested

Ciprofloxacin 400 MG/200 ML Intravenous Solution — full drug profile →
Levofloxacin 750 MG — full drug profile →

Conditions studied

QTc Prolongation, Hyperglycemia, Hypoglycemia — all drugs for QTc Prolongation, Hyperglycemia, Hypoglycemia →

Sponsor

Beni-Suef University

Who can join

Adults 18 to 70, any sex, with QTc Prolongation, Hyperglycemia, Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare intravenous levofloxacin and ciprofloxacin regarding their risk on the corrected QT interval (QTc) prolongation and dysglycemia in diabetic and non-diabetic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04456712 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 2 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04456712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing